Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα |
| |
Authors: | Elirosa Minniti Jo Ann W Byl Laura Riccardi Claudia Sissi Michela Rosini Marco De Vivo Anna Minarini Neil Osheroff |
| |
Institution: | 1. Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy;2. Laboratory of Molecular Modeling and Drug Discovery, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy;3. Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232-0146, USA;4. Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, Italy;5. IAS-5/INM-9 Computational Biomedicine, Forschungszentrum Jülich, Wilhelm-Johnen-Straβe, 52428 Jülich, Germany;6. Department of Medicine (Hematology/Oncology), Vanderbilt University School of Medicine, Nashville, TN 37232-6307, USA;7. VA Tennessee Valley Healthcare System, Nashville, TN 37212, USA |
| |
Abstract: | It has been proposed that xanthone derivatives with anticancer potential act as topoisomerase II inhibitors because they interfere with the ability of the enzyme to bind its ATP cofactor. In order to further characterize xanthone mechanism and generate compounds with potential as anticancer drugs, we synthesized a series of derivatives in which position 3 was substituted with different polyamine chains. As determined by DNA relaxation and decatenation assays, the resulting compounds are potent topoisomerase IIα inhibitors. Although xanthone derivatives inhibit topoisomerase IIα-catalyzed ATP hydrolysis, mechanistic studies indicate that they do not act at the ATPase site. Rather, they appear to function by blocking the ability of DNA to stimulate ATP hydrolysis. On the basis of activity, competition, and modeling studies, we propose that xanthones interact with the DNA cleavage/ligation active site of topoisomerase IIα and inhibit the catalytic activity of the enzyme by interfering with the DNA strand passage step. |
| |
Keywords: | Xanthone derivative Polyamines DNA topoisomerase IIα Anticancer drug Catalytic inhibitor DNA cleavage |
本文献已被 ScienceDirect 等数据库收录! |
|